You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daclizumab

Showing 1 - 25 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia Trial run by the NHLBI (Daclizumab)

Terminated
Has Results
  • Aplastic Anemia
  • +2 more
  • Daclizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021

Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)

Completed
Has Results
  • Kidney Transplantation
  • +2 more
  • London, United Kingdom
    West London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021

DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,

Completed
Has Results
  • DiGeorge Anomaly
  • +4 more
  • Cultured Thymus Tissue for Implantation (CTTI)
  • +8 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 23, 2022

Diabetes, Type 1 Trial in Canada, United States (Mycophenolate mofeteil (MMF), Daclizumab (DZB), Placebo control for

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Mycophenolate mofeteil (MMF)
  • +3 more
  • Los Angeles, California
  • +10 more
Apr 27, 2020

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)

Completed
  • Leukemia
  • +3 more
  • daclizumab
  • +4 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019

Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Worldwide (Daclizumab)

Terminated
Has Results
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • Daclizumab
  • Tampa, Florida
  • +10 more
Sep 25, 2019

Diabetes, Type I Trial in Miami (islets)

Active, not recruiting
  • Diabetes Mellitus, Type I
  • Miami, Florida
    University of Miami, Diabetes Research Institute
Mar 1, 2022

Newly Diagnosed With Type 1 Diabetes Trial in Indianapolis (Zenapax)

Completed
  • Newly Diagnosed With Type 1 Diabetes
  • Indianapolis, Indiana
    Indiana University - Riley Hospital for Children
Aug 10, 2020

Uveitis With Biologic Drugs in Resistant Cases

Not yet recruiting
  • Uveitis
  • Biologic drugs
  • (no location specified)
Apr 21, 2022

Diabetes, Type I Trial in Oslo, Stockholm, Uppsala (Low Molecular Weight Sulfated Dextran (LMW-SD), Heparin, CellCept®

Completed
  • Diabetes Mellitus, Type I
  • Low Molecular Weight Sulfated Dextran (LMW-SD)
  • +8 more
  • Oslo, Norway
  • +2 more
Sep 22, 2021

Relapsing Remitting Multiple Sclerosis Trial in Worldwide (Pleneva TM BGC20-0134, Placebo)

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • Pleneva TM BGC20-0134
  • Placebo
  • Gent, Belgium
  • +34 more
Jun 2, 2022

Kidney Transplant Rejection Trial in Gainesville (Phenotypic Personalized Medicine Dosing)

Not yet recruiting
  • Kidney Transplant Rejection
  • Phenotypic Personalized Medicine Dosing
  • Gainesville, Florida
    University of Florida Health Shands
Jun 20, 2022

Stomach Tumor Trial in Chengdu (Capeox regimen combined with Sintilimab and Bevacizumab)

Not yet recruiting
  • Stomach Neoplasm
  • Capeox regimen combined with Sintilimab and Bevacizumab
  • Chengdu, China
    Liu Ming
Nov 28, 2022

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial run by the NINDS (DAC-HYP)

Completed
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • DAC-HYP
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 31, 2019

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (BIIB019 (Daclizumab), trivalent seasonal influenza vaccine)

Completed
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • BIIB019 (Daclizumab)
  • trivalent seasonal influenza vaccine
  • Brno, Czechia
  • +64 more
Apr 11, 2018

Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis Trial in Worldwide (BIIB019 (Daclizumab))

Terminated
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • Multiple Sclerosis
  • BIIB019 (Daclizumab)
  • Phoenix, Arizona
  • +221 more
Nov 11, 2019

Diabetes, Type 1 Trial in Chicago (Islet Cell Transplant, Islet Cell Transplant plus)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Islet Cell Transplant
  • Islet Cell Transplant plus
  • Chicago, Illinois
    University of Illinois at Chicago
Mar 11, 2021

Multiple Sclerosis Trial in Saint Louis (SOMAscan)

Recruiting
  • Multiple Sclerosis
  • SOMAscan
  • Saint Louis, Missouri
    Washington University in St Louis
Apr 25, 2022

Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

Active, not recruiting
Has Results
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 13, 2022

Kidney Failure, Chronic Trial in Baltimore (Thymoglobulin, Daclizumab, Plasmapheresis)

Completed
Has Results
  • Kidney Failure, Chronic
  • Baltimore, Maryland
    The Johns Hopkins University, School of Medicine
Dec 19, 2017

Patients Active and Listed for Lung Transplantation Trial in Baltimore (Zenapax)

Completed
  • Patients Active and Listed for Lung Transplantation
  • Baltimore, Maryland
    Johns Hopkins University Hospital
Dec 21, 2017

Multiple Sclerosis Trial in Latham (Cladribine Tablets)

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022

Renal Insufficiency Trial in Barcelona (ATeGe-Fresenius)

Completed
  • Renal Insufficiency
  • Barcelona, Spain
    Department of HPB Surgery and Transplants, Hospital Vall d´Hebro
Feb 11, 2020

Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)

Recruiting
  • Ulcerative Colitis
  • Thromboembolism
  • Madrid, Spain
    Hospital Universitario de La Princesa
Aug 2, 2022